Reported 2,500,000 shares, up 620,000 (33.0%) from the prior quarter.
Reported value 11.9%; share count 33.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-12-31 | 105408000 |
| 2024-03-31 | 97923200 |
| 2024-06-30 | 0 |
| 2025-06-30 | 3770700 |
| 2025-09-30 | 0 |
| 2026-03-31 | 164675000 |
| 2026-06-30 | 316845800 |
| 2026-09-30 | 354600000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 2,500,000 | +620,000 (33.0%) | 9.16% | $354,600,000 | 2026-11-16 | |
| Q2 2026 | Added | 1,880,000 | +630,000 (50.4%) | 7.4% | $316,845,800 | 2026-08-14 | |
| Q1 2026 | New | 1,250,000 | +1,250,000 (0.0%) | 4.6% | $164,675,000 | 2026-05-15 | |
| Q3 2025 | Reduced | 0 | -30,000 (-100.0%) | 0 | $0 | 2025-11-14 | |
| Q2 2025 | New | 30,000 | +30,000 (0.0%) | 0.2% | $3,770,700 | 2025-08-14 | |
| Q2 2024 | Reduced | 0 | -710,000 (-100.0%) | 0 | $0 | 2024-08-14 | |
| Q1 2024 | Reduced | 710,000 | -90,000 (-11.3%) | 8.1% | $97,923,200 | 2024-05-14 | |
| Q4 2023 | New | 800,000 | +800,000 (0.0%) | 11.17% | $105,408,000 | 2024-02-13 |
Who else reported the position
877 managers reported * NEUROCRINE BIOSCIENCES INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Added | 14,856,103 | +1,144,496 | 0.03% | $2,107,189,670 | 9 qtrs |
| Dodge & Cox | Reduced | 5,504,578 | -80,129 | 0.42% | $780,769,344 | 13 qtrs |
| JPMorgan Chase & Co | Reduced | 5,292,589 | -1,106,085 | 0.04% | $733,010,216 | 48 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Added | 5,060,036 | +85,953 | 0.03% | $717,715,506 | 3 qtrs |
| STATE STREET CORPORATION | Added | 4,807,975 | +422,377 | 0.02% | $681,963,174 | 54 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 4,580,803 | +35,464 | 0.01% | $649,741,098 | 3 qtrs |
| AQR CAPITAL MANAGEMENT LLC | Reduced | 3,062,385 | -755,652 | 0.13% | $422,547,761 | 35 qtrs |
| Vestal Point Capital LP This report | Added | 2,500,000 | +620,000 | 9.16% | $354,600,000 | 3 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 2,300,697 | -35,200 | 0.44% | $326,330,862 | 32 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 2,127,482 | -11,295 | 0.02% | $301,038,376 | 54 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 2,500,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.